DV
Dividend Vision

GTBP — GT Biopharma Inc

GT Biopharma Inc (GTBP)

Its deepest 1-year drawdown was 83.8%.

GTBP is an equity fund focused on the biotechnology sector that has been operating since 1984. The fund's distribution rate and expense ratio information are not currently available. The fund appeals primarily to investors seeking exposure to biopharma companies, though potential investors should verify current fund details and performance metrics before evaluating it.

GTBP key facts

Asset type
Stock
Asset class
Equity
Inception date
11/05/1984
Last close
$0.30
Market cap
$12,834,787
Average volume
798700.0
Payment date
08/21/2017
Beta
0.838
Payout ratio
0.0
Forward P/E
17.331
EPS
$-6.46